Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ATCC KCL22-s; Chronic myeloid leukemia; Human (Homo sapiens)
Supplier: ATCC CRL3349
KCL22-s is a cell line exhibiting lymphoblast-like morphology that was isolated in 1999 from the pleural effusion of a 32-year-old female with chronic myeloid leukemia at blast crisis. The paired KCL22-s and KCL22-r clones are useful cell line models of sensitivity and resistance to a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia. It can be used for immune system disorder research.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?